Skip to content

Life Quality Determinant Assessment of Fibromyalgia Patients

Life Quality Determinant Assessment of Fibromyalgia Patients Related to Health Devices

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02482714
Acronym
FIBROQUALLIFE
Enrollment
93
Registered
2015-06-26
Start date
2015-09-30
Completion date
2020-03-12
Last updated
2021-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Quality of Life, Physical Activity

Brief summary

The primary purpose is the evaluation of life quality of Fibromyalgia patients. The investigators' main hypothesis includes the role of geographical, sociological, psychological and physical activity on life quality.

Interventions

Have subject do moderate physical activity.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age group : 20 to 60 * Male or female * American College of Rheumatology criteria * Social Security beneficiary * Informed consent of the patient * Patient informed of the medical examination prior to inclusion * Patient residing in the Bas-Rhin area

Exclusion criteria

* No medical objections to performing a stress test * Any cardio-respiratory and musculoskeletal affection preventing physical activity * Any particular clinical form disease * Patient in situation of exclusion * Subject incapacity to understand informed consent * Patient deprived of freedom or under the protection of a conservator * Pregnancy or breast-feeding

Design outcomes

Primary

MeasureTime frame
Quality of Life with Fibromyalgia score on questionnary QIF (Quality of Life with Fibromyalgia)6th month

Secondary

MeasureTime frame
Score on questionnary Short Form (36) SF366th month
Measurement of displacement with Global Positioning System GPS6th month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026